書誌事項
- タイトル別名
-
- Clinical study of sitafloxacin in male nongonococcal urethritis
この論文をさがす
抄録
The clinical efficacy and safety of sitafloxacin (STFX), a fluoroquinolone compound, were evaluated in male patients with nongonococcal urethritis treated orally 7 days with 50 mg b.i.d. of STFX. Clinical efficacy was evaluated based on criteria for evaluation of clinical efficacy of antimicrobial agents on urinary tract infection (draft, fourth edition).<BR>Overall clinical efficacy was 88.6%(31/35) for nongonococcal urethritis and, by diagnosis, 85.2%(23/27) for nongonococcal-chlamydial urethritis, 100%(7/7) for Mycoplasma genitalium-negative nongonococcalnonchlamydial urethritis, and excellent in 1 case with M. genitalium-positive nongonococcal urethritis. Eradication by microorganism was 96.0%(24/25) for Chlamydia trachomatis, 88.9%(8/9) for Ureaplasma urealyticum, and 100%(7/7) for Ureaplasma parvum. Two of 3 strains of M. genitalium were eradicated. The incidence of adverse reactions was 27.3%(12/44), the most common being diarrhea. All symptoms were mild or moderate.<BR>Results suggest that STFX was effective and safe in the treatment of male nongonococcal urethritis.
収録刊行物
-
- 日本化学療法学会雑誌
-
日本化学療法学会雑誌 56 (Supplement1), 130-138, 2008
公益社団法人 日本化学療法学会
- Tweet
詳細情報
-
- CRID
- 1390001206288107136
-
- NII論文ID
- 10021192900
- 130004102779
-
- NII書誌ID
- AN10472127
-
- ISSN
- 18845886
- 13407007
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可